You are here: Home Projects Climate and Biodiversity Catalyse

Climate Action to Advance Healthy Societies in Europe (CATALYSE)

Funding

European Commission

Duration

2022 - ongoing

Lead party

  • WEcR
  • Consortium members

    • FUNDACIÓN PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA (ISGlobal), Spain
    • INTERNATIONALES INSTITUT FUER ANGEWANDTE SYSTEMANALYSE (IIASA), Austria
    • UMIT TIROL – Private Universität für Gesundheitswissenschaften und -technologie GmbH (UMIT TIROL), Austria
    • AZIENDA SANITARIA LOCALE ROMA 1 (ASL ROMA1), Italy
    • HERTIE SCHOOL GEMMEINNUTZIGE GMBH (Hertie School), Germany
    • UMEÅ UNIVERSITET (UMU), Sweden
    • MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV (MPG), Sweden
    • SIMBIOTICA SL (VIZ), Spain
    • ESCOLA SUPERIOR DE COMERC INTERNACIONAL (ESCI-UPF), Spain
    • HEALTH AND ANVIRONMENT ALLIANCE HEAL AISBL (HEAL), Spain
    • EuroCARE, Germany
    • E3-MODELLING AE (E3M), Greece
    • FACULTY OF MEDICINE OF THE UNIVERSITY OF PORTO (FMUP), Portugal
    • Servei Meteorològic de Catalunya (METEOCAT), Spain
    • ILMATIETEEN LAITOS (IL (FMI)), Finland
    • MASK-air (MASK-air), France
    • BARCELONA SUPERCOMPUTING CENTER-CENTRO NACIONAL DE SUPERCOMPUTACION, Spain
    • UNIVERSITAT ZURICH (UZH), Switzerland
    • UNIVERSITY COLLEGE LONDON (UCL), UK
    • THE UNIVERSITY OF BIRMINGHAM (UoB), UK
    • THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (UOXF), UK

    Overview

    Despite clear signs that the impacts of climate change are escalating, the global response has been inadequate. Traditional scientific efforts have fallen short of providing knowledge and tools that have been broadly applied in decision-making, and innovative approaches to knowledge translation are needed. Therefore the overall objective of CATALYSE is to provide new knowledge, data, and innovative tools on: i) the relationships between changes in environmental hazards caused by climate change, ecosystems, and human health; ii) the health co-benefits of climate action; iii) the role of health evidence in decision making; and iv) the societal implications of climate change for health systems.

    Specific objectives and WPs (apart from coordination)

  • 1. To develop an integrated indicator framework and repository to track the status of health-relevant outcomes of climate actions.
  • 2. To quantify the health co-benefits and harms resulting from mitigation measures outside of the health sector and account for these impacts in an integrated social cost-benefit analysis.
  • 3. To develop innovative surveillance and forecasting tools (incl EWS) that facilitate timely and effective response to environmental health hazards caused by climate change.
  • 4. To investigate how citizens, decision makers, and other selected stakeholders engage with evidence regarding the health impacts of climate change, and to identify constraints and opportunities to facilitate engagement.
  • 5. To investigate the most effective strategies for climate change adaptation and mitigation for health systems, with specific focus on vulnerable populations including those occupationally exposed to hazards induced by climate change.
  • Contributions of EuroCARE

  • In WP1.1, CAPRI will contribute to the interested indicator framework and repository.
  • In WP2 CAPRI contributes to the analysis of health co-benefits of climate mitigation covering following tasks:
  • T2.1 Scenario development on climate mitigation relying on model linkages from EUCLIMIT (without GLOBIOM)
  • T2.5 Co-benefits in food systems (linkage U OXF, CAPRI, GAINS)
  • T2.7 Integrated social cost benefit analysis.